Immune system development and function in prolactin receptor-deficient mice

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 576-582

  Bouchard, Brigitte ^a   Ormandy, Christopher J ^b   Di Santo, James P ^c   Kelly, Paul A ^a  

^a INSERM   (France)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MITOGENIC AGENT; PROLACTIN; PROLACTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HYPOPHYSECTOMY; IMMUNE RESPONSE; IMMUNOMODULATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOCYTOPENIA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TARGET CELL; THYMUS ATROPHY;

ANIMALS; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; IMMUNE SYSTEM; IMMUNOGLOBULINS; ISOANTIGENS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGENS; RECEPTORS, PROLACTIN; T-LYMPHOCYTES; THYMUS GLAND; TUMOR CELLS, CULTURED;

EID: 0033565392     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bole-Feysot, C., V. Goffin, M. Edery, N. Binart, and P. A. Kelly. 1998. Prolactin and its receptor: actions, signal transduction pathways, and phenotypes observed in prolactin receptor knockout mice. Endocr. Rev. 19:225.
2. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293.
3. Nagy, E., and I. Berczi. 1978. Immunodeficiency in hypophysectomized rats. Acta Endocrinol. 89:530.
4. Nagy, E., I. Berczi, G. E. Wren, S. L. Asa, and K. Kovacs. 1983. Immunomodulation by bromocriptine. Immunopharmacology 6:231.
5. Gala, R. R. 1991. Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 198:513.
6. Matera, L., A. Cesano, G. Bellone, and E. Oberholtzer. 1992. Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes. Brain Behav. Immun. 6:409.
7. Fletcher-Chiappini, S. E., M. M. Compton, H. A. La Voie, E. B. Day, and R. J. Witorsch. 1993. Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticylolytic effects. Proc. Soc. Exp. Biol. Med. 202:345.
8. Clevenger, C. V., S. W. Alktmann, and M. B. Prystowsky. 1992. Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes. Science 253:77.
9. Montgomery, D. W., J. A. Lafevre, E. D. Ulrich. C. R. Adamson, and C. F. Zukoshi. 1990. Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 127:2601.
10. Montgomery, D. W., G. K. Shen, E. D. Ulrich, L. L. Steiner, P. R. Parrish, and C. F. Zukoski. 1992. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology 131:3019.
11. Russell, D. H., L. Matrisian, R. Kibler, D. F. Larson, B. Poulos, and B. E. Magun. 1984. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem. Biophys. Res. Commun. 121:899.
12. Gagnerault, M. C., P. Touraine, W. Savino, P. A. Kelly, and M. Dardenne. 1993. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J. Immunol. 150:5673.
13. Ormandy, C. J., A. Camus, J. Barra, D. Damotte, B. K. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, et al. 1997. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:167.
14. Clement-Lacroix, P., C. Ormandy, L. Lepescheux, P. Ammann, D. Damotte, V. Goffin, B. Bouchard, M. Amling, M. Gaillard-Kelly, N. Binart, et al. 1999. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology 140:96.
15. Roes, J., and K. Rajewsky. 1993. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J. Exp. Med. 177:45.
16. Andersson, A., W. J. Dai, J. P. Di Santo, and F. Brombacher. 1998. Early IFN-γ production and innate immunity during Listeria monocytogenes infection in the absence of NK cells. J. Immunol. 161:5600.
17. Murphy, W. J., S. K. Durum, and D. L. Longo. 1993. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178:231.
18. Gaufo, G. O., and M. C. Diamond. 1996. Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc. Natl. Acad. Sci. USA 93:4165.
19. Mukherjee, P., A. M. Mastro, and W. C. Hymer. 1990. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126:88.
20. Papiernik, M., M. L. de Moraes, C. Pontoux, F. Vasseur, and C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion, and 1L-2 dependency. Int. Immunol. 10:371.
21. Clevenger, C. V., D. H. Russell, P. M. Appasamy, and M. B. Prystowsky. 1990. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. USA 87:6460.
22. Brombacher, F., and M. Kopf. 1996. Innate versus acquired immunity in listeriosis. Res. Immunol. 147:505.
23. Bernton, E. W., M. S. Meltzer, and J. W. Holaday. 1988. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401.
24. Spangelo, B. L., N. R. Hall, P. C. Ross, and A. L. Goldstein. 1987. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 14:11.
25. Vidaller, A., L. Llorente, F. Larrea, J. P. Mendez, J. Alcocer-Varela, and D. Alarcon-Segovia. 1986. T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin. Immunol. Immunopathol. 38:337.
26. Vidaller, A., F. Guadarrama, L. Llorente, J. B. Mendez, F. Larrea, A. R. Villa, and D. Alarcon-Segovia. 1992. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient. J. Clin. Immunol. 12:210.
27. Gerli, R., C. Riccardi, I. Nicoletti, S. Orlandi, C. Cernetti, F. Spinozzi, and P. Rambotti. 1987. Phenotypic and functional abnormalities of T lymphocytes in pathological hyperprolactinemia. J. Clin. Immunol. 7:463.
28. McMurray, R., D. Keisler, K. Kanuckel, S. Izui, and S. E. Walker. 1991. Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunol. 147:3780.
29. Horseman, N. D., W. Zhao, E. Montecino-Rodriguez, M. Tanaka, K. Nakashima, S. J. Engle, F. Smith, E. Markoff, and K. Dorshkind. 1997. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16:6926.
30. Montecino-Rodriguez, E., R. Clark, A. Johnson, L. Collins, and K. Dorshkind. 1996. Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. J. Immunol. 157:3334.
31. Murphy, W. J., S. K. Durum, M. R. Anver, and D. L. Longo. 1992. Immunologic and hematologic effects of neuroendocrine hormones: studies on DW/J dwarf mice. J. Immunol. 148:3799.
32. Baroni, C. D., N. Fabris, and G. Bertoli. 1969. Effects of hormones on development and function of lymphoid tissues: synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. Immunology 17:303.
33. Goffin, V., K. T. Shiverick, P. A. Kelly, and J. A. Martial. 1996. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr. Rev. 17:385.
34. Gertler, A., J. Grosclaude, and J. Djiane. 1997. Interaction of lactogenic hormones with prolactin receptors. Ann. NY Acad. Sci. 839:177.
35. Freemark, M., M. Comer, G. Komer, and S. Handwerger. 1987. A unique placental lactogen receptor: implications for fetal growth. Endocrinology 120:1865.
36. Freemark, M., and M. Comer. 1989. Purification of a distinct placental lactogen receptor, a new member of the growth hormone/prolactin receptor family. J. Clin. Invest. 83:883.
37. Piccoletti, R., P. Maroni, P. Bendinelli, and A. Bemelli-Zazzera. 1994. Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J. 303:429.
38. Clevenger, C. V., T. Torigoe, and J. C. Reed. 1994. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J. Biol. Chem. 269:5559.
39. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4-deficient mice. Science 254:707.
40. von Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519.
41. Parganas, E., D. Wang, D. Stravopodis, D. J. Topham, J. C. Marine, S. Teglund, E. F. Vanin, S. Bodner, O. R. Colamonici, J. M. Van Deursen, et al. 1998. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385.
42. Yu-Lee, L. Y. 1997. Molecular actions of actions of prolactin in the immune system. Proc. Soc. Exp. Biol. Med. 215:35.
43. Clevenger, C. V., D. O. Freier, and J. B. Kline. 1998. Prolactin receptor signal transduction in cells of the immune system. J. Endocrinol. 157:187.